Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
New England BioLabs, Inc. 2016. Transfection of Cas9 RNP (ribonucleoprotein) into adherent cells using the Lipofectamine® RNAiMAX. protocols.io https://dx.doi.org/10.17504/protocols.io.frjbm4nCopy Citation Copied
URL: https://dx.doi.org/DOI:10.17504/protocols.io.frjbm4n
Authors: New England BioLabs, Inc.
Group: New England Biolabs (NEB)
Summary: Cas9 nuclease may be used in vivo to create targeted genome modifications. There are several ways in which to introduce Cas9-guide RNA complexes into cells. Here we present a method for the transfection of Cas9 RNP’s into HEK293 FT cells using Thermo Fisher Lipofectamine® RNAiMAX. This is a ‘reverse transfection’ method that uses a final concentration of 10 nM RNP per transfection in a 96-well culture plate.
Affiliations: ,
Version: 1
Publication Date: 2016
Expand AllComing soon.
Source: